Secondary osteoporosis induced by anticoagulant drugs?;Sekundäre osteoporose durch antikoagulantien?

Orthopade

Volumn 30, Issue 7, 2001, Pages 451-455

  Riess, H ^a   Loew, A ^a   Himmelreich, G ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Coumarins; Heparins; Low molecular weight heparins; Osteoporosis; Pregnancy

Indexed keywords

ANTIVITAMIN K; CORTICOSTEROID; COUMARIN; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BONE ATROPHY; DRUG SAFETY; GENETIC PREDISPOSITION; HUMAN; IMMOBILIZATION; MALABSORPTION; OSTEOPOROSIS; PREGNANCY; REVIEW; RISK FACTOR;

ADMINISTRATION, ORAL; ADULT; ANTICOAGULANTS; BONE AND BONES; BONE DENSITY; CLINICAL TRIALS; COUMARINS; DOUBLE-BLIND METHOD; FEMALE; FRACTURES, BONE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IMMOBILIZATION; META-ANALYSIS; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VITAMIN K;

EID: 0034919423     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001320170077     Document Type: Review

References (30)

1. Effect of medication on biomechanical properties of rabbit bones: Heparin induced osteoporosis
2. Heparin-induced osteopenia: An apprasial
3. Bone density changes in pregnant women treated with heparin: A prospective, longitudinal study
4. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry
5. Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitro
6. The effects of standard and low molecular weight heparin on bone nodule formation in vitro
7. Dietrary vitamin K intakes are associated with hip fracture but not with bone minderal density in elderly men and women
8. Warfarin in prevention of heterotopic ossification
9. Long-term use of oral anticoagulants and the risk of fracture
10. Changes in bone density after exposure in oral anticoagulantes: A meta-analysis
11. Prospective evaluation of bone densitiy in pregnant women receivieng the low molecular weight heparin enoxaparin sodium
12. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
13. The effects of long-term heparin therapy during pregnancy on bone densitiy. A prospective matched cohort study
14. Vitamin K intake and hip fractures in women: A prospective study
15. Secondary osteoporosis
16. Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats (2000)
17. Structural determinants of the capacity of heparin to inhibit collagen synsthesis in 21-day fetal rat calvaria
18. Warfarin use and risk for osteoporosis in elderly women. Study of osteoporotic fractures research group
19. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin
20. A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats
21. Long-term administration of heparin and heparin fractions and osteoporosis in experimental animals
22. Low-molecular-weight heparin (dalteparin) demonstrated a weaker effect on rat bone metabolism compared with heparin
23. The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects
24. Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral desnities: Effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin
25. The effects of low molecular-weight and standard heparin on calcium loss from fetal rat calcaria
26. Osteoporosis and vertebral collapse following low-dose, low molecular weight heparin therapy in a young patient
27. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
28. Risk factors for reduced bone densitiy in haemodialysis patients
29. Osteoclastogenesis inhibitory factor (OCIF)/OPG
30. Effects of short-term low-dose heparin administration on biochemical parameters of bone turnover